Latest News

Male alopecia agents ranked by efficacy in meta-analysis


 

FROM JAMA DERMATOLOGY

Adverse event considerations important

Importantly, however, strong consideration needs to be given to adverse-event profiles, as well as patient comorbidities in selecting agents, the editorial authors asserted.

With 1 mg finasteride, for instance, potential adverse events include decreased libido, erectile dysfunction, decreased ejaculatory volume, reduction in sperm count, testicular pain, depression, and gynecomastia, they noted.

And while finasteride appears to be associated with a decreased risk of prostate cancer, those receiving the drug who do develop prostate cancer may be diagnosed with higher-grade prostate cancer; however, that “might be related to tissue sampling artifact,” the editorial authors said.

Less has been published on dutasteride’s adverse-event profile, and that, in itself, is a concern.

Antonella Tosti, MD, Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery at the University of Miami, Miami, Florida Dr. Antonella Tosti

Dr. Antonella Tosti

Overall, “as more direct-to-consumer companies treating male AGA emerge, it is especially important that the potential risks of these medications be made clear to patients,” they added.

Further commenting on the analysis to this news organization, Antonella Tosti, MD, the Fredric Brandt Endowed Professor of Dermatology and Cutaneous Surgery at the University of Miami, said the study offers some important insights – and caveats.

“I think this is a very interesting study, but you have to consider what works for your patients,” she said.

Dr. Tosti noted that the 5-mg dose of minoxidil is a concern in terms of side effects. “That dose is pretty high and could feasibly cause some hypertrichosis, which can be a concern to men as well as women.”

She agrees that the lack of data on side effects with dutasteride is also a concern, especially in light of some of the known side effects with other agents.

“That’s why I don’t use it very much in younger patients – because I’m afraid it could potentially affect their fertility,” Dr. Tosti said.

In general, Dr. Tosti said she finds a combination of agents provides the best results, as many clinicians use.

“I find dutasteride (0.5 mg/day) plus oral minoxidil (1-2.5 mg/day) plus topical 5% minoxidil is the best combination,” she said.

The authors and Dr. Tosti disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

For suspected hair disorders, consider trichoscopy before biopsy
MDedge Family Medicine
An 11-year-old female with a 3-year history of alopecia
MDedge Family Medicine
Gray hair goes away and squids go to space
MDedge Family Medicine
Pediatric alopecia areata in the U.S. has increased twofold since 2009, study finds
MDedge Family Medicine
Androgenetic alopecia fuels negative emotions and poor quality of life
MDedge Family Medicine
FDA inaction on hair loss drug’s suicide, depression, erectile dysfunction risk sparks lawsuit
MDedge Family Medicine
New finasteride lawsuit brings renewed attention to psychiatric, ED adverse event reports
MDedge Family Medicine
JAK inhibitor provides impressive hair growth for patients with alopecia areata
MDedge Family Medicine
Hair follicle miniaturization common in persistent chemo-induced alopecia, case series suggests
MDedge Family Medicine
Alopecia tied to a threefold increased risk for dementia
MDedge Family Medicine